Medizone International, Inc. (OTCBB: MZEI) (http://medizoneint.com)
Yesterday we saw a huge move in Medizone International – on the same date the Agency for Healthcare Research and Quality Report was released stating HOSPITAL ACQUIRED INFECTIONS NEED URGENT ATTENTION..
Medizone is delivering a cost effective solution for Hospital Acquired Infections. The media and Congress are focusing on this issue. It is front and center and Medizone is in the sweet, sweet spot of being on the verge of bringing a potential solution to market.
I was pleased to note this morning (April 14, 2010) that the New York Times reported on the Agency for Healthcare Research and Quality Report released yesterday which noted HOSPITAL ACQUIRED INFECTIONS NEED URGENT ATTENTION.
The Report focused on Hospital Acquired Infections, noting that the, “problem of hospital-acquired infections remains as resistant to cure as the germs that contribute to an estimated 100,000 deaths a year, according to an annual government study issued Tuesday.”
Despite threats of governmental sanctions, hospitals continue to see increased rates of post-operative bloodstream infections which increased by eight percent and catheter-associated urinary tract infections which increased by four percent.
There was no change in the incidence of bloodstream infections caused by the placement of catheters in central veins. The only positive news came from a 12 percent reduction in the rate of post-operative pneumonia.
Dr. Carolyn M. Clancy, the agency’s director, pointed out that projects across the country had shown remarkable success in reducing infection rates by adhering to basic standards for hand hygiene, disinfection of patients, sterile handling of equipment and proper use of antibiotics. But at many hospitals those successes have yet to overcome an entrenched medical culture.
‘Kathleen Sebelius, the secretary of health and human services, called the trend troubling but said the new health care law would ”help turn these numbers around.” Under the law, hospitals with high rates of infections will be penalized by the government starting in the 2015 fiscal year.
The AsepticSure™ hospital sterilization system is a portable, affordable, easily operated system that can be used by trained maintenance staff. It is placed in the center of the room to be cleaned. Vents and doors are then sealed with an easily and cleanly removable 3M-tape product.
The AsepticSure™ equipment is turned on from outside of the room through a remote wireless computer interface. The room is filled with a unique and patented gas formula that is ozone (O3) based to specific humidity and charge strength. Following the charge period the sterilization process is remotely turned off and a separate technology is employed that restores the atmosphere inside the room to EPA standards.
The entire process, start to finish, takes 80 to 90 minutes at which time the room will have been cleared of pathogens to the 6 log sterilization standard. The room is opened and the equipment is then ready to move on to the next space to be treated, leaving the treated room sterile of pathogens with a fresh, oxygen (O2) freshness.
Medizone International’s successful decontamination by AsepticSure™ to the 6 log standard or greater on hospital surfaces represents solution for Hospital Acquired Infections and MORE.
Medizone International has demonstrated successful decontamination by AsepticSure™ to the 6 log standard or greater has been demonstrated with:
- C.difficile
- E coli
- Pseudomonas aeruginous
- MRSA
- VRE
- Bacillius subtilis
- Hospitals
- Sports training facilities
- Schools
- Critical infrastructure
Contact: Medizone International, Inc. (OTCBB: MZEI)
(See Medizone International Video)
http://www.medizoneint.com
Telephone: 415-868-0300
Fax: 415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970
This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.
Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
Medizone International, Inc.
Post Office Box 742
Stinson Beach, CA 94970
Telephone: 415-868-0300
Fax: 415-868-2344
This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.
